Grupo Multilaser (MLAS3) Q4 2024 earnings summary

Executive summary

• Revenue in 2024 was R$3.39B, down 3.2% year-over-year, mainly due to discontinued low-margin lines and supply chain disruptions, but operational recovery and portfolio optimization drove margin improvement.

• Gross profit surged 311.7% to R$786.3M, with gross margin rising to 23.2%–24.1%, reflecting improved product mix and operational efficiency.

• EBITDA turned positive at R$41.4M (1.2% margin), a major turnaround from a loss of R$658.5M in 2023, driven by cost controls and portfolio renewal.

• Net loss narrowed to -R$321.2M from -R$836.2M in 2023, with 78%–80% of the 2024 loss due to FX impacts; excluding FX, net loss would have been -R$69.1M.

• Cash and equivalents ended at R$744.6M, with a net cash position of R$96.8M and gross debt of R$647.8M.

Financial highlights

• Revenue from continued operations grew 2.5% in 2024, offsetting declines from discontinued lines.

• Gross margin improved to 23.2%–24.1% (from 5.5% in 2023), with continued portfolio gross margin at 25.3%.

• Operating expenses fell: selling expenses down 7.7% and G&A down 2.9% year-over-year.

• Net cash position at year-end was R$96.8M, with 65.1% of debt long-term and 82.2% in foreign currency.

• Inventory book value reduced by R$24.1M compared to Q4 2023; discontinued product inventory now only 0.2% of total.

Outlook and guidance

• Focus for 2025 is on profitability, portfolio optimization, and operational efficiency, with conservative procurement and inventory management.

• New manufacturing partnerships (e.g., Royal Enfield, Hisense, Oppo) and ramp-up of existing projects are expected to drive growth.

• Expense reduction and margin improvement remain top priorities, with ongoing structural reviews.

• Macro risks remain: high FX volatility, rising interest rates, and potential consumption slowdown.

• FX volatility remains a risk, but hedging and price pass-through strategies are in place.